A detailed history of Cynosure Management, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Cynosure Management, LLC holds 3,598 shares of MRK stock, worth $364,009. This represents 0.07% of its overall portfolio holdings.

Number of Shares
3,598
Previous 3,221 11.7%
Holding current value
$364,009
Previous $425,000 4.71%
% of portfolio
0.07%
Previous 0.08%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$123.8 - $132.96 $46,672 - $50,125
377 Added 11.7%
3,598 $445,000
Q1 2024

May 10, 2024

SELL
$113.24 - $131.95 $2.93 Million - $3.41 Million
-25,866 Reduced 88.93%
3,221 $425,000
Q4 2023

Feb 14, 2024

BUY
$100.18 - $109.02 $1.87 Million - $2.03 Million
18,645 Added 178.56%
29,087 $3.17 Million
Q3 2023

Nov 14, 2023

SELL
$102.95 - $114.33 $13,795 - $15,320
-134 Reduced 1.27%
10,442 $1.08 Million
Q2 2023

Aug 14, 2023

BUY
$108.61 - $118.38 $1.15 Million - $1.25 Million
10,576 New
10,576 $1.22 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $256B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Cynosure Management, LLC Portfolio

Follow Cynosure Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cynosure Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cynosure Management, LLC with notifications on news.